Drug Profile
Eglumetad
Alternative Names: Eglumegad; LY-354740Latest Information Update: 29 Oct 2009
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Anxiolytics; Neuroprotectants; Small molecules; Smoking cessation therapies
- Mechanism of Action Glutamate agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders; Neurological disorders; Panic disorder; Psychotic disorders; Schizophrenia; Seizures; Smoking withdrawal